Literature DB >> 19920215

Dynamic insulin sensitivity index: importance in diabetes.

Gianluigi Pillonetto1, Andrea Caumo, Claudio Cobelli.   

Abstract

The classical minimal model (MM) index of insulin sensitivity, S(I), does not account for how fast or slow insulin action takes place. In a recent work, we proposed a new dynamic insulin sensitivity index, S(I)(D), which is able to take into account the dynamics of insulin action as well. The new index is a function of two MM parameters, namely S(I) and p(2), the latter parameter governing the speed of rise and decay of insulin action. We have previously shown that in normal glucose tolerant subjects S(I)(D) provides a more comprehensive picture of insulin action on glucose metabolism than S(I). The aim of this study is to show that resorting to S(I)(D) rather S(I) is even more appropriate when studying diabetic patients who have a low and slow insulin action. We analyzed insulin-modified intravenous glucose tolerance test studies performed in 10 diabetic subjects and mixed meal glucose tolerance test studies exploiting the triple tracer technique in 14 diabetic subjects. We derived both S(I) and S(I)(D) resorting to Bayesian and Fisherian identification strategies. The results show that S(I)(D) is estimated more precisely than S(I) when using the Bayesian approach. In addition, the less labor-intensive Fisherian approach can still be used to obtain reliable point estimates of S(I)(D) but not of S(I). These results suggest that S(I)(D) yields a comprehensive, precise, and cost-effective assessment of insulin sensitivity in subjects with impaired insulin action like impaired glucose tolerant subjects or diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920215      PMCID: PMC2838530          DOI: 10.1152/ajpendo.90340.2008

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  15 in total

1.  Minimal model S(I)=0 problem in NIDDM subjects: nonzero Bayesian estimates with credible confidence intervals.

Authors:  Gianluigi Pillonetto; Giovanni Sparacino; Paolo Magni; Riccardo Bellazzi; Claudio Cobelli
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

2.  Numerical non-identifiability regions of the minimal model of glucose kinetics: superiority of Bayesian estimation.

Authors:  Gianluigi Pillonetto; Giovanni Sparacino; Claudio Cobelli
Journal:  Math Biosci       Date:  2003-07       Impact factor: 2.144

3.  The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects.

Authors:  A Avogaro; P Vicini; A Valerio; A Caumo; C Cobelli
Journal:  Am J Physiol       Date:  1996-03

4.  SAAM II: Simulation, Analysis, and Modeling Software for tracer and pharmacokinetic studies.

Authors:  P H Barrett; B M Bell; C Cobelli; H Golde; A Schumitzky; P Vicini; D M Foster
Journal:  Metabolism       Date:  1998-04       Impact factor: 8.694

5.  Insulin secretion and sensitivity in newly diagnosed NIDDM Caucasians in the UK.

Authors:  D R Owens; S D Luzio; P A Coates
Journal:  Diabet Med       Date:  1996-09       Impact factor: 4.359

6.  Mechanisms of the kinetic defect in insulin action in obesity and NIDDM.

Authors:  J J Nolan; B Ludvik; J Baloga; D Reichart; J M Olefsky
Journal:  Diabetes       Date:  1997-06       Impact factor: 9.461

7.  The GENNID Study. A resource for mapping the genes that cause NIDDM.

Authors:  L J Raffel; D C Robbins; J M Norris; E Boerwinkle; R A DeFronzo; S C Elbein; W Fujimoto; C L Hanis; S E Kahn; M A Permutt; K C Chiu; J Cruz; D A Ehrmann; R P Robertson; J I Rotter; J Buse
Journal:  Diabetes Care       Date:  1996-08       Impact factor: 19.112

8.  Quantitative estimation of insulin sensitivity.

Authors:  R N Bergman; Y Z Ider; C R Bowden; C Cobelli
Journal:  Am J Physiol       Date:  1979-06

9.  A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Insulin Resistance Atherosclerosis Study.

Authors:  M F Saad; R L Anderson; A Laws; R M Watanabe; W W Kades; Y D Chen; R E Sands; D Pei; P J Savage; R N Bergman
Journal:  Diabetes       Date:  1994-09       Impact factor: 9.461

10.  Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism.

Authors:  Ananda Basu; Chiara Dalla Man; Rita Basu; Gianna Toffolo; Claudio Cobelli; Robert A Rizza
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

View more
  6 in total

1.  Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data.

Authors:  Roberto Burattini; Micaela Morettini; Francesco Di Nardo; Massimo Boemi
Journal:  Med Biol Eng Comput       Date:  2011-03-30       Impact factor: 2.602

2.  Diabetes: Models, Signals, and Control.

Authors:  Claudio Cobelli; Chiara Dalla Man; Giovanni Sparacino; Lalo Magni; Giuseppe De Nicolao; Boris P Kovatchev
Journal:  IEEE Rev Biomed Eng       Date:  2009-01-01

Review 3.  Effects of bariatric surgery on glucose homeostasis and type 2 diabetes.

Authors:  David Bradley; Faidon Magkos; Samuel Klein
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

4.  Imaging free zinc levels in vivo - what can be learned?

Authors:  Luis De Leon-Rodriguez; Angelo Josue M Lubag; A Dean Sherry
Journal:  Inorganica Chim Acta       Date:  2012-06-25       Impact factor: 2.545

5.  Good agreement between hyperinsulinemic-euglycemic clamp and 2 hours oral minimal model assessed insulin sensitivity in adolescents.

Authors:  Anne-Marie Carreau; Danielle Xie; Yesenia Garcia-Reyes; Haseeb Rahat; Kai Bartlette; Cecilia Diniz Behn; Laura Pyle; Kristen J Nadeau; Melanie Cree-Green
Journal:  Pediatr Diabetes       Date:  2020-07-31       Impact factor: 3.409

Review 6.  The oral minimal model method.

Authors:  Claudio Cobelli; Chiara Dalla Man; Gianna Toffolo; Rita Basu; Adrian Vella; Robert Rizza
Journal:  Diabetes       Date:  2014-04       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.